NIH Patents and Patent Applications

This list includes non-provisional and PCT patent filings.

CSV download of the complete patent data set.

For information on patent application codes, country codes, and patent status, see the Patents FAQ.

Tips:
Reset the Search Filters to go back to the initial display of all records.
Sort columns by clicking on the blue column headers.
The Search function searches across all columns.
To filter results by Lead IC, Country, or Application, type or use the dropdown menu.

Lead IC Reference Number Title Country Patent Application Type Application Number Date Filed Patent Number Date Issued Patent Status Patent PDF
NIAID E-241-2004-0-IT-09 Method of Detecting Cancer Based On Immune Reaction To BORIS IT EP 05799643.1 Issued
NIAID E-241-2004-0-GB-08 Method of Detecting Cancer Based On Immune Reaction To BORIS GB EP 05799643.1 Issued
NIAID E-241-2004-0-PCT-02 Method of Detecting Cancer Based On Immune Reaction To BORIS PCT PCT PCT/US2005/33796 Expired
NCI E-313-2005-0-US-01 A Method To Develop B-Cell Epitope Based Effective Vaccine Modalities For Smallpox For Both Immune-Competent And Immune-Compromised Individuals US 60/722,082 Abandoned
NINDS E-274-2004-0-PCT-02 Methods Of Identifying And Treating VHL Associated Tumors and Sporadic Renal Cell Carcinoma, Other VHL Sporadic Count-erpart Tumors and Non-Tumor Lesions Which Co-express EPO and the EPO Receptor PCT PCT PCT/US2005/033850 Abandoned
NIDDK E-063-2007-0-US-01 PRODRUG DELIVERY OF A3 ADENOSINE ANTAGONISTS FOR GLAUCOMA THERAPY US 60/718,642 Abandoned
NCI E-004-2005-3-US-01 Human Monoclonal Antibodies Against Hendra And Hipah US 60/718,902 Abandoned
NIDDK E-310-2005-0-US-01 Prodrug Delivery Of A3 Adenosine Receptor Antagonists For Glaucoma Therapy US 60/718,642 Abandoned
NHGRI E-146-2005-0-US-01 Quantification Of Allele-Specific RNA Expression US 60/718,321 Abandoned
NHGRI E-236-1999-0-US-22 Methods and Compositions Useful of Modulation of Angiogenesis Using Tyrosine Kinase SRC US DIV 11/230,995 7585841 Expired PDF
NIAID E-095-2000-3-US-01 AMELIORATION OF INFLAMMATORY ARTHRITIS BY TARGETING THE PRE-LIGAND ASEEMBLY DOMAIN OF TUMOR NECROSIS FACTOR RECEPTORS US 60/717,589 Abandoned
NCI E-319-2005-0-US-01 Triapine-induced Tumor Cell Radiosensitization US 60/718,172 Abandoned
NCI E-307-2002-0-US-03 CONTIGUOUS CAPILLARY ELECTROSPRAY SOURCES AND ANALYTICAL DEVICE US National Stage 10/529,967 7544932 Issued PDF
NCI E-152-2007-0-US-10 Non-M Non-O HiV Strains, Fragments And Uses US CON 11/226,240 7534877 Expired PDF
NHLBI E-134-2005-0-US-01 Imaging And Reconstruction Of Partial Field Of View In Phase Contrast MRI US ORD 11/227,406 7285954 Issued PDF
NINDS E-125-2004-0-PCT-02 Grid Etcher PCT PCT PCT/US2005/032657 Abandoned
NHLBI E-298-2005-0-US-01 Active MRI Compatible And Visible IMRI Catheter US 60/716,503 Abandoned
NCI E-081-1999-2-US-02 Redox-Stable, Non-Phosphorylated Cyclic Peptide Inhibitors of SH2 Domain Binding to Target Protein, Conjugates Thereof, Compositions and Methods of Synthesis and Use US DIV 11/224,819 7259142 Expired PDF
NHLBI E-347-2004-0-US-01 Poly-ADP-ribose (PAR) Hydrolase: A New PARG-like Enzyme US 60/716,807 Abandoned
NIDA E-269-2006-2-US-01 Opioid Receptor Ligands And Methods For Their Preparation US CIP 11/224,706 7728001 Issued PDF
NIDA E-269-2006-2-PCT-02 Opioid Receptor Ligands And Methods For Their Preparation PCT PCT PCT/US2005/032505 Abandoned
NCI E-307-2005-0-US-01 CYP1B1 Genotype US 60/716,439 Abandoned
NCI E-328-2002-0-US-03 Synthesis of Proteins by Cell-free Protein Expression US National Stage 10/548,634 Abandoned
NIAID E-319-2004-2-US-02 Optimized Vaccines To Provide Protection Against Ebola And Other Viruses US 60/715,874 Abandoned
NINDS E-150-2005-0-US-01 METHODS AND COMPOSITIONS FOR INHIBITING CELL DEATH OR ENHANCING CELL PROLIFERATION US 60/715,722 Abandoned
NIDCR E-298-2004-0-PCT-02 Transcytosis of Adeno-Associated Viruses PCT PCT PCT/US2005/031837 Expired
NINDS E-239-2005-0-US-01 Notch Activation Promotes Stem Cell Survival In Vitro And In Vivo US 60/715,935 Abandoned
NCI E-309-2005-0-US-01 Use Of Replicators To Prevent Gene Silencing US 60/715,113 Abandoned
NIDCR E-035-2010-2-PCT-01 INTEGRIN CD18 IS A NOVEL STROMAL STEM CELL MARKER AND FUNCTIONS TO PROMOTE OSTEOGENESIS PCT PCT COMB PCT/US2005/032220 Expired
NCI E-307-2004-0-PCT-02 Beta-Glucuronidase Cleavable Prodrugs of O6-Benzylguanine and O6-Benzyl-2-Deoxyguanosine PCT PCT PCT/US2005/031506 Expired
NCI E-307-2004-0-EP-05 Beta-Glucuronidase Cleavable Prodrugs of O6-Benzylguanine and O6-Benzyl-2-Deoxyguanosine EP National Stage 05794349.0 Abandoned
NIDCR E-253-2005-0-US-01 Inhibition Of SARS By The Synthethic Triterpenoid 2-cyano-3,12-dioxooleana-1,9-dien-28-oic-acid (CDDO) US 60/713,724 Abandoned
NIAID E-324-2005-0-US-01 Conformationally Stabilized HIV Envelope Immunogens, and Triggering HIV-1 to Reveal Cryptic V3-Loop Epitopes US 60/713,725 Abandoned
NCI E-307-2004-0-CA-04 Beta-Glucuronidase Cleavable Prodrugs of O6-Benzylguanine and O6-Benzyl-2-Deoxyguanosine CA National Stage 2579660 Abandoned
NCI E-307-2004-0-AU-03 Beta-Glucuronidase Cleavable Prodrugs of O6-Benzylguanine and O6-Benzyl-2-Deoxyguanosine AU National Stage 2005282562 Abandoned
NIDDK E-248-2004-0-IN-07 PURINE DERIVATIVES AS A3 AND A1 ADENOSINE RECEPTOR AGONISTS IN National Stage 337/MUMNP/2007 Abandoned
NIDDK E-248-2004-0-AU-03 PURINE DERIVATIVES AS A3 AND A1 ADENOSINE RECEPTOR AGONISTS AU National Stage 2005285284 Abandoned
NHLBI E-276-2004-2-AU-02 Methods for Assessing Atherosclerosis AU National Stage 2005282636 Abandoned
NIDDK E-248-2004-0-CA-04 PURINE DERIVATIVES AS A3 AND A1 ADENOSINE RECEPTOR AGONISTS2,601,996 CA National Stage 2601996 Abandoned
NIDDK E-248-2004-0-PCT-02 A3 and A1 Adenosine Receptor Agonists PCT PCT PCT/US2005/031678 Expired
NHLBI E-276-2004-2-JP-05 Methods for Assessing Atherosclerosis JP National Stage 2007-530430 Abandoned
NHLBI E-276-2004-2-PCT-01 Methods for Assessing Atherosclerosis PCT PCT COMB PCT/US2005/031469 Expired
NIDDK E-248-2004-0-BR-10 Purine Derivatives as A3 and A1 Adenosine Receptor Agonists BR National Stage PI0515030-2 Abandoned
NIDDK E-248-2004-0-EP-05 PURINE DERIVATIVES AS A3 AND A1 ADENOSINE RECEPTOR AGONISTS EP National Stage 05795036.2 Abandoned
NHLBI E-276-2004-2-EP-04 Methods for Assessing Atherosclerosis EP National Stage 05796294.6 Abandoned
NHLBI E-276-2004-2-CA-03 Methods for Assessing Atherosclerosis CA National Stage 2577819 Abandoned
NIDDK E-248-2004-0-IL-06 PURINE DERIVATIVES AS A3 AND A1 ADENOSINE RECEPTOR AGONISTS IL National Stage 181716 Abandoned
NCI E-057-1994-3-JP-08 MELANOMA ANTIGENS AND THEIR USE IN DIAGNOSTIC AND THERAPEUTIC METHODS JP DIV 2005-253464 Expired
NEI E-110-2005-0-US-01 Use of IL-23 or IL-23R Antagonists to Treat Uveitis US 60/713,792 Abandoned
NIEHS E-305-2005-0-US-01 DMT-DERIVATIVE COMPOUNDS AND RELATED COMPOSITIONS AND METHODS OF USE US 60/714,071 Abandoned